Immunotherapy biotech company
NantKwest shares opened at $37 in their trading debut, 48% above their
IPO price. Patrick Soon-Shiong ,NantKwest CEO, discusses the...
ENJOY GREECE
We Explore, Find, Check & Propose You for the Truth - Enjoy GREECE - Enjoy EUROPE - Enjoy WORLD
